Gehrisch Anja, Dörr Wolfgang
Department of Radiotherapy and Radiooncology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
Strahlenther Onkol. 2007 Jan;183(1):36-42. doi: 10.1007/s00066-007-1594-4.
To quantify the effect of sodium selenite (selenium) on radiation-induced oral mucositis (mouse) after subcutaneous or topical administration.
Mucosal ulceration of the lower epithelium of mouse tongue was analyzed. Selenium (5 mug) was applied subcutaneously (s.c.) or locally, 60 min or 30 min prior to irradiation, respectively. In combination with single-dose irradiation, a single selenium application was given. With daily fractionated irradiation (3 Gy/fraction) for 1 week (days 0-4), selenium was administered at all 5 days of irradiation. With ten fractions over 2 weeks, selenium was applied in week 1, week 2, or both. All fractionation protocols were terminated by graded test doses to generate full dose-effect curves.
In a single-dose control experiment, the ED(50) (dose after which ulcer induction is expected in 50% of the mice) was 12.9 +/- 1.6 Gy. Selenium increased the ED(50) to 17.7 +/- 2.6 Gy (s.c.; p = 0.0003) and 16.3 +/- 3.0 Gy (local; p = 0.0104). The ED(50) for test irradiation after 5 x 3 Gy was 7.4 +/- 2.2 Gy. Subcutaneous administration of selenium resulted in an ED(50) of 11.5 +/- 2.0 Gy (p = 0.0015), local application yielded an ED(50) of 10.0 +/- 2.1 Gy (p = 0.0284). The ED(50) for test irradiation after 10 x 3 Gy/2 weeks was 8.0 +/- 1.7 Gy. Subcutaneous or local administration of selenium in week 1 yielded a significant increase in ED(50) to 10.5 +/- 1.0 Gy (p = 0.0069) and 10.7 +/- 1.0 Gy (p = 0.0039), respectively. By clear contrast, selenium administration in week 2 had no significant effect. Administration in both weeks resulted in an ED(50) of 9.1 +/- 2.0 Gy (s.c.; p = 0.2747) and 9.7 +/- 1.4 Gy (local; p = 0.0541).
Administration of sodium selenite during clinically relevant fractionated irradiation protocols has a significant effect during the initial treatment phase, i.e., week 1 in the mouse. Therefore, in clinical radiotherapy, the latent time to manifestation of confluent mucositis may be significantly prolonged, and hence the burden for the patient clearly reduced by selenium.
量化亚硒酸钠(硒)皮下或局部给药后对辐射诱导的口腔黏膜炎(小鼠)的影响。
分析小鼠舌下部上皮的黏膜溃疡情况。分别在照射前60分钟或30分钟皮下或局部给予硒(5微克)。与单次剂量照射联合使用时,给予单次硒给药。在每日分次照射(3 Gy/分次)1周(第0 - 4天)期间,在照射的所有5天给予硒。在2周内分10次照射时,硒在第1周、第2周或两周均给药。所有分次方案均通过分级测试剂量终止以生成完整的剂量 - 效应曲线。
在单次剂量对照实验中,ED(50)(预期50%小鼠出现溃疡的剂量)为12.9±1.6 Gy。硒使ED(50)增加至17.7±2.6 Gy(皮下;p = 0.0003)和16.3±3.0 Gy(局部;p = 0.0104)。5×3 Gy照射后的测试照射的ED(50)为7.4±2.2 Gy。皮下给予硒导致ED(50)为11.5±2.0 Gy(p = 0.0015),局部给药产生的ED(50)为10.0±2.1 Gy(p = 0.0284)。2周内10×3 Gy照射后的测试照射的ED(50)为8.0±1.7 Gy。第1周皮下或局部给予硒使ED(50)显著增加至10.5±1.0 Gy(p = 0.0069)和10.7±1.0 Gy(p = 0.0039)。相比之下,第2周给予硒无显著影响。两周均给药导致皮下给药的ED(50)为9.1±2.0 Gy(p = 0.2747),局部给药的ED(50)为9.7±1.4 Gy(p = 0.0541)。
在临床相关的分次照射方案中给予亚硒酸钠在初始治疗阶段(即小鼠的第1周)有显著效果。因此,在临床放射治疗中,融合性黏膜炎出现的潜伏期可能会显著延长,从而硒可明显减轻患者的负担。